About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, September 15th, 2015

The QualityStocks
Daily Stock List


Black Stallion Oil & Gas, Inc. (BLKG)

Today we choose to highlight Black Stallion Oil & Gas, Inc. (BLKG), here at the QualityStocks Daily Newsletter.

Founded in 2011, Black Stallion Oil & Gas, Inc. is an energy exploration company that lists on the OTC Markets Group’s OTCQB. Black Stallion’s emphasis is on developing America's plentiful shale oil and gas resources. The Company previously went by the name Secure It Corp. It changed its name to Black Stallion Oil and Gas, Inc. in September of 2013. Black Stallion Oil & Gas has its head office in Los Angeles, California.

The Company is focusing on the Alberta Basin Bakken in northwest Montana. This region shares characteristics with close by established basins producing significant amounts of natural gas. Black Stallion has secured the right to acquire 50 percent ownership in the large 12,233-acre Woodrow Prospect in Teton county, Montana, within the Alberta Basin Bakken fairway.

The Company’s 51-101 report (June 2014) estimates the Woodrow Prospect to represent net recoverable prospective resources for Black Stallion Oil & Gas of 80.8 million barrels of oil (MMBO) and 16.9 billion cubic feet of natural gas (Bcf).

The Woodrow Prospect is approximately 6 miles from quality pipeline infrastructure. This infrastructure has served Canadian production and the once prolific Cut Bank oil and gas field; 7 within 12 miles from the Pondera Field (30 MMBO); and 40 miles from a refinery at Great Falls, Montana.

This week, Black Stallion Oil & Gas appointed industry veteran Mr. Michael L. Pinnell as its Vice President of Exploration. Mr. Pinnell's experience in the field dates back 45 years to when he started his career with Exxon. In addition, Black Stallion also announced the appointment of Geologists Mr. Irving J. Prentice and Mr. Case Lewis to its Advisory Board.

Mr. George Drazenovic, Black Stallion’s Chief Executive Officer, said: "We welcome Mr. Pinnell, Mr. Prentice and Mr. Lewis to the Black Stallion team. Together, they represent over 90 years of industry experience that we will draw on extensively as we move forward with our development plans for the sizeable Woodrow Prospect in the Alberta Basin Bakken."

Black Stallion Oil & Gas, Inc. (BLKG), closed Tuesday's trading session at $1.41, down 11.32%, on 563,061 volume with 942 trades. The average volume for the last 60 days is 212,427 and the stock's 52-week low/high is $0.50/$2.39.

Titan Pharmaceuticals, Inc. (TTNP)

VectorVest, The Street, PennyTrader and OTCtipReporter reported on Titan Pharmaceuticals, Inc. (TTNP), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Titan Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in South San Francisco, California. It is developing proprietary therapeutics chiefly for the treatment of central nervous system (CNS) disorders. The Company’s core asset is Probuphine®. This product is the first slow-release implant formulation of buprenorphine hydrochloride (buprenorphine). Titan Pharmaceuticals’ shares trade on the OTC Bulletin Board.

Probuphine® is the first product to employ ProNeura™. This is a novel, proprietary, long-term drug delivery technology. The ProNeura™ technology has the potential to be used in developing products for the treatment of other chronic conditions, such as Parkinson's disease. The Probuphine New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration (FDA) in October 2012, seeking approval for the treatment of opioid dependence.

The design of Probuphine® is to maintain a stable, round-the-clock blood level of the medicine in patients for up to six months following a single treatment. In 2011, a seven-day transdermal patch formulation of buprenorphine for the treatment of chronic pain was launched in the U.S.

Probuphine® is an investigational subdermal implant for the maintenance treatment of opioid dependence in adult patients. Titan Pharmaceuticals’ aim is to enter into one or more collaborations with capable pharmaceutical companies to commercialize Probuphine® in the U.S. and global markets, and to develop, potentially, the product for the treatment of chronic pain.

The Company is also entitled to royalty revenue of 8-10 percent of net sales of Fanapt® (iloperidone). This is an atypical antipsychotic compound being marketed in the U.S. for the treatment of schizophrenia by Novartis Pharma AG under a sub-license agreement based on a licensed U.S. patent that expires in October 2016 (does not include a possible six month pediatric extension).

Titan Pharmaceuticals announced in November 2014 completion of enrollment in the continuing Phase 3 study of Probuphine®, its investigational subdermal implant for the maintenance treatment of opioid dependence. Titan’s partner, Braeburn Pharmaceuticals, is sponsoring the study. This past June, Titan reported positive topline results from the Phase 3 double blind, double dummy clinical study of Probuphine®. The study met the pre-specified primary endpoint of non-inferiority, and also all secondary efficacy endpoints.

This month, Titan Pharmaceuticals reported financial results for Q2 ended June 30, 2015. Total revenue in Q2 2015 was approximately $0.8 million versus revenue of approximately $0.9 million in Q2 2014. Q2 2015 and 2014 revenues consisted entirely of license revenue and reflect the amortization of the upfront license fee received from development and commercialization partner Braeburn Pharmaceuticals in December 2012.

Net loss for Q2 2015 was approximately $2.3 million, or approximately $0.02 per share, versus approximately $0.8 million, or approximately $0.01 per share in Q2 2014. At June 30, 2015, the Company had approximately $11.5 million in cash. Titan believes this is sufficient to fund planned operations into the fourth quarter of 2016.

Titan Pharmaceuticals, Inc. (TTNP), closed Tuesday's trading session at $0.68, up 3.03%, on 117,299 volume with 41 trades. The average volume for the last 60 days is 172,518 and the stock's 52-week low/high is $0.44/$0.989.

CytoDyn, Inc. (CYDY)

PennyStockRumors and AllPennyStocks reported previously on CytoDyn, Inc. (CYDY), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

CytoDyn, Inc. is a biotechnology company centering on developing subcutaneously delivered humanized cell-specific monoclonal antibodies (mAbs) as entry inhibitors for the treatment and prevention of Human Immunodeficiency Virus (HIV). The Company has one of the leading mAbs under development for HIV infection - PRO 140. OTCQB-listed CytoDyn has its corporate headquarters in Vancouver, Washington.

PRO 140 has finished Phase 2 clinical trials with demonstrated antiviral activity in man. PRO 140 is CytoDyn’s novel self-injectable antibody for the treatment of HIV. PRO 140 is a humanized monoclonal antibody directed against CCR5, a molecular portal that HIV uses to enter cells.

PRO 140 belongs to a new class of HIV/AIDS therapeutics - viral-entry inhibitors. The intention of these are to protect healthy cells from viral infection. PRO 140 blocks the HIV co-receptor CCR5. Clinical trial results so far indicate that it does not affect the normal function of the cell.

PRO 140 has been the subject of four Phase 1/1b and two Phase 2a clinical trials. Results from Phase 1/1b and Phase 2a human clinical trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV. The Company’s intention is to continue to develop PRO 140 as a therapeutic anti-viral agent in persons infected with HIV.    

PRO 140 has also been designated a "fast track" product candidate by the Food and Drug Administration (FDA). The PRO 140 antibody appears to be a strong antiviral agent leading to potentially fewer side effects and less frequent dosing requirements versus daily drug therapies now in use.

CytoDyn has reached an agreement with the FDA on the Company's previously submitted Phase 3 protocol synopsis for PRO 140. It submitted the full Phase 3 protocol to the FDA on May 4, 2015. Its Phase 3 protocol provides for a 25-week study with 300 HIV patients.

CytoDyn’s recently completed Phase 2b treatment substitution trial demonstrated that 98 percent of all patients treated with PRO 140 successfully passed four weeks of monotherapy without virologic failure.

CytoDyn announced this past June that recent Company research data has expanded the potential clinical indications for PRO 140, now in Phase 3 for the treatment of HIV, to include certain inflammatory diseases, autoimmunity, transplantation and cancer.

In early August, CytoDyn announced that it started its first clinical site for its Phase 3 trial.  Dr. Nader Pourhassan, President and Chief Executive Officer, said, "We are very pleased with Amarex Clinical Research's performance in initiating new sites for our current Phase 3 study. We believe that our recent $7.3 million equity raise will continue to support an expeditious commencement of our Phase 3 trial."

CytoDyn, Inc. (CYDY), closed Tuesday's trading session at $0.73, up 2.82%, on 72,656 volume with 38 trades. The average volume for the last 60 days is 77,980 and the stock's 52-week low/high is $0.63/$1.30.

Medbox, Inc. (MDBX)

Money Morning reported this month on Medbox, Inc. (MDBX), SmallCapVoice, The Street, and StreetInsider did earlier, and we highlight the Company today, here at the QualityStocks Daily Newsletter.

OTCQB-listed Medbox, Inc. provides specialized consulting services to the legal marijuana industry. The Los Angeles, California-headquartered Company also sells associated patented products. These include its Medbox medical dispensing system and medical vaporization devices. It also has its wholly-owned subsidiary, Vaporfection International, Inc. Via this subsidiary, it provides an industry award-winning medical line of vaporizer products.

Medbox is a foremost dispensary infrastructure/licensing specialist, patented technology provider, and partner to the cannabis industry. The Company provides its patented systems, software and consulting services to pharmacies, alternative medicine dispensaries, as well as local governments in the United States.
The Company uses its expertise to work with investors and entrepreneurs who look to enter the cannabis sector. It provides them with a high quality, turn-key solution, comprising licensing, site selection, permitting, design, and full build-out. Medbox has become a leader in providing compliance, safety, security, oversight and operational expertise to the medical and recreational cannabis industry nationwide.

Medbox is also developing supplementary services customized to the alternative medicine industry. These include real estate acquisitions and subsequent lease programs to alternative medicine dispensaries and cultivation centers, and alternative medicine dispensary and cultivation management services. The Company also engages in merchant services and armored transport for cash deposits - ancillary services catered to the alternative medicine industry.

Medbox features patented systems that dispense medication based on biometric identification (fingerprint sample). Its systems enable pharmacies, assisted living facilities, prisons, hospitals, doctors’ offices, and alternative medicine clinics to help manage employee possession of sensitive drugs. In a retail environment characteristic in most alternative medicine clinics, the system lets the clinics document that the user is a registered patient and that the patient has a valid and unexpired authorization from a physician to possess and use the medicine dispensed.

Medbox has its patented “Medbox”. The biometrically sealed inventory control, storage and dispensing technology ensures safe and secure access to marijuana in medical and recreational dispensaries.

Medbox’s Vaporfection has signed an exclusive North American distribution agreement for its "miVape" vaporizer with VaporNation. The miVape vaporizer is a self-contained, USB-rechargeable unit, which uses medical grade, food-safe and heat resistant materials to deliver the healthiest experience possible. VaporNation is the largest wholesaler and online retailer of vaporizers.

Last week, Medbox announced it engaged an experienced Israel-based medical marijuana consultancy. This is as Medbox prepares to enter the cultivation market and work with licensed independent growers.

Mr. Jeff Goh, President and interim CEO of Medbox, said, "We are aligning ourselves with world class experts, as we enter a new phase in our company's development. It is critical that products produced on our property by licensed independent growers be of the highest pharmaceutical quality to ensure efficacy and consistency for patients, as well as to drive sustainable revenues."

Medbox, Inc. (MDBX), closed Tuesday's trading session at $0.111, up 4.72%, on 768,176 volume with 122 trades. The average volume for the last 60 days is 3,718,025 and the stock's 52-week low/high is $0.05/$15.20.

mCig, Inc. (MCIG)

SmallCapVoice and TopPennyStockMovers reported on mCig, Inc. (MCIG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, mCig, Inc. is a foremost provider of advanced technologies and solutions to the global cannabis industry. It owns the mCig and Vapolution brands. Furthermore, the Company has a 47 percent stake in VitaCig (VTCQ), makers of the VitaStik, which is a disposable vitamin vaporizer. mCig manufactures and markets best-selling portable and home vaporizers, extraction related equipment, CBD Rich Hemp Oil-derived products, and related nutraceuticals based on natural compounds found in Cannabis and Hemp plants. The Company is based in Beverly Hills, California.

mCig offers electronic cigarettes and related products through its online store at mcig.org. In addition, it offers its products through its wholesale, distributor, and retail programs.  The mCig® was purpose built for the consumption of a variety of plant materials versus being pre-packaged with plant material or vapor. This permits one to consume the plant material of their choice.

Through its wholly-owned subsidiary VitaCig®, mCig is harnessing mobile vaporization technology for medical delivery applications. mCig launched its first consumer product, The VitaCig®. This is a nicotine-free device that looks and feels like an electronic cigarette (eCig).

The VitaCig® delivers a water-vapor of natural flavors, vitamins, and phytonutrients. The VitaCig® launched in April of 2014 in three flavor categories. These are Relax, Refresh, and Energize. The Company has plans for more flavor categories and targeted medical applications in the future.

mCig has started CBD product line releases and the launch of a website specifically geared for vaporizer users at: www.justCBDoil.com. It has unveiled its new CHILL! Just CBD Oil Vape Pen.

This week, mCig announced that it signed a Letter of Intent agreement (LOI) to acquire Security Grade Protective Services, Inc. The expectation is that the acquisition will close on or before July 19, 2015. Security Grade Protective Services is a full-service security firm specializing in the cannabis industry. Revenues from Security Grade are expected to earn mCig $2.5 million in 2016 as the Company realizes its marketing and sales efforts for its systems and services in states beyond Colorado.

mCig, Inc. (MCIG), closed Tuesday's trading session at $0.032, down 6.71%, on 906,235 volume with 57 trades. The average volume for the last 60 days is 801,668 and the stock's 52-week low/high is $0.025/$0.319.


The QualityStocks
Company Corner


Dominovas Energy Corp. (DNRG)

The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.0825, up 11.49%, on 3,101,846 volume with 271 trades. The stock’s average daily volume over the past 60 days is 7,280,293 and its 52-week low/high is $0.0035/$0.45.

Dominovas Energy Corp. announced the signing of a Memorandum of Understanding with the Al-Rushaid Group's Al-Rushaid Technologies. The document platforms discussions regarding the development of a relationship to pursue common business interests between Dominovas Energy Corporation and Al-Rushaid Technologies (Dhahran, Kingdom of Saudi Arabia). Both Companies have agreed to identify common business interests, strategies, and approaches for establishing a profitable working relationship that will allow for the successful execution of various endeavors concerning their collective business mandates.

Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.

At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.

In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.

Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer

Dominovas Energy Corp. Blog

Dominovas Energy Corp. News:

Dominovas Energy Signs Memorandum of Understanding With the Al-Rushaid Group's Al-Rushaid Technologies

Dominovas Energy Tours Sub-Saharan Africa

Dominovas Energy Announces Details of Upcoming Conference Call

On the Move Systems, Inc. (OMVS)

The QualityStocks Daily Newsletter would like to spotlight On the Move Systems, Inc. (OMVS). Today, On the Move Systems, Inc. closed trading at $0.595, off by 8.46%, on 84,667 volume with 73 trades. The stock’s average daily volume over the past 60 days is 69,193, and its 52-week low/high is $0.2501/$11.04.

On the Move Systems, Inc.: Customers today want a variety of shopping choices, and retailers that fail to provide a wide array of fulfillment options or channels – from traditional brick and mortar stores to catalogs to online – are more and more often ending up in the dustbin of business history. On the Move Systems’ (OMVS) innovative shared economy courier service can help retailers and other outlets improve their e-commerce order fulfillment side of that equation.

On the Move Systems, Inc. (OMVS) specializes in the development of cutting-edge technology to transform and synchronize freight supply chain operations for a broad range of industries. The company is exploring new online tools to reduce costs and increase convenience in the tourism and travel industry, as well as new opportunities in trucking. OMVS works with a premier group of international providers to offer its services in two key divisions: Trucking Logistics and Inter-modal Freight.

Logistics are critical to the success of any operation. OMVS's Trucking Logistics division operates as one of the most competitive, full-service transportation logistics providers in the United States. Utilizing the company's ISTx Platform, this division helps customers strategize how to get from one point to another, as well as solves some of the toughest logistics challenges on the road today. OMVS's Trucking Logistics technology provides customers increased visibility, minimal-cost route effectiveness, and delivery assurance.

OMVS's Intermodal Freight division offers seamless cargo continuation, tracking, shipping and receiving of goods anywhere in the world. The company's customer service teams and drivers communicate through the ISTx Platform allowing for flexibility, control and monitoring of each freight shipment. OMVS continues to research and explore the most effective and resourceful tools in order to effectively serve customers with unique shipping requirements in the billion dollar trucking industry.

In his more than 20 years of experience, OMVS president and CEO Robert Wilson has cultivated vast expertise as an executive and financial consultant for companies in aviation, energy, oil and gas, IT and healthcare. In addition to his work valuing and assessing small-to-middle market companies, Wilson has also served as both an officer and director of such client companies. Wilson applies his expertise in the transportation business and investment banking to spearhead OMVS's new initiative to create a new kind of online transportation platform to an international market Disclaimer

On the Move Systems, Inc. Company Blog

On the Move Systems, Inc. News:

OMVS: Shared Economy Courier Service Can Solve Multi-Channel Sourcing Needs

OMVS Pursuing Retail Partnerships for Proposed Shared Economy Courier Service

OMVS: Trends Show Need for Shared Economy Solutions

The Aristocrat Group Corp. (ASCC)

The QualityStocks Daily Newsletter would like to spotlight The Aristocrat Group Corp. (ASCC). Today, The Aristocrat Group Corp. closed trading at $0.80, off by 20.00%, on 26,173 volume with 22 trades. The stock’s average daily volume over the past 60 days is 14,241, and its 52-week low/high is $0.51/$6.00.

Aristocrat Group Corp.: It’s no secret why Ultra-Premium Handcrafted RWB Vodka continues to climb in popularity and distribution: the Aristocrat Group Corp. (OTCBB: ASCC) uses only locally sourced ingredients and a passion for quality distillation to produce an award-winning vodka infused with American pride. “We set out to create a product that we would be proud to call America’s Vodka, and we’ve accomplished that goal,” said ASCC CEO Robert Federowicz. “There is no finer American-made vodka than RWB, and our only challenge now is to keep spreading the word about it.”

The Aristocrat Group Corp. (ASCC) is a brand management company specializing in the discovery and promotion of unique brands with mass market appeal. The company strategizes to capitalize on unprecedented brand-building opportunities, and is working to build a portfolio of successful brands to compete alongside industry leaders like Moet Hennessy, Louis Vuitton, Diageo PLC, and Brown-Forman Corp.

Luxuria Brands, an ASCC subsidiary, is tasked with brand management and sustainability, specifically in the beverage alcohol sector, where the company will develop and market brands using strategic, cross-cultural branding initiatives that engage businesses and consumers. Vodka boasts a significantly high market share, accounting for 25 percent of all distilled spirits sold in the United States. What this means for ASCC investors is that they have a remarkable chance to capitalize on a proven commodity and business model for distribution.

To this accord, ASCC's current portfolio of premium luxury goods brands includes top-shelf distilled spirits like RWB Vodka, an ultra-premium handcrafted spirit that has already met remarkable success, including multiple awards. The market for vodka is estimated to be at almost 60 million cases per year in the United States alone, and beverages priced at a premium level are garnering top-dollar returns for businesses and investors. Strategizing to capitalize on this powerful sector, ASCC plans to debut a second lifestyle vodka brand later this year.

ASCC's experienced and visionary management team is committed to creating a solid foundation for innovative technologies and models, ranging from mobile couponing to social engagement, that drive business forward. Building on its established presence in the lucrative beverage alcohol sector, ASCC is emerging as a trusted platform where fledgling ideas turn into commercial successes. Disclaimer

The Aristocrat Group Corp. Company Blog

The Aristocrat Group Corp. News:

ASCC Uses Local Ingredients and Old-Fashioned Craftsmanship to Produce America’s Vodka

ASCC-Sponsored Artist Curtis Braly Performs for His Largest Crowd Yet

ASCC’s Big Box Vodka is a Hit with Focus Groups

Fastfunds Financial Corp. (FFFC)

The QualityStocks Daily Newsletter would like to spotlight Fastfunds Financial Corp. (FFFC). Today, Fastfunds Financial Corp. closed trading at $0.00015, up 50.00%, on 11,196,226 volume with 14 trades. The stock’s average daily volume over the past 60 days is 24,682,393, and its 52-week low/high is $0.0001/$0.12.

Fastfunds Financial Corp. (FFFC) operates through two wholly owned subsidiaries, Cannabis Angel, Inc. and The 420 Development Corporation, to build a portfolio of revenue-generating companies that provide ancillary services to the burgeoning cannabis industry. The company also operates majority-owned subsidiary Financiera Moderna, Inc., which offers financial services to the underserved Hispanic community. FFFC's strategy to participate in the marijuana industry is through the development of four separate business verticals for the emerging U.S. cannabis industry.

Through its 49% stake in Cannabis Merchant Financial Solutions, Inc. (CMFS), FFFC entered the Financial Service business vertical. CMFS developed the Green Card and Tommy Chong Green Card, a reloadable stored value card with a rewards feature, and the Tommy Chong Frequent Buyers Card, which functions as a gift card or rewards card. FFFC is developing a national group of master resellers, distributors and sales representatives for these card products.

As the cannabis industry continues to develop, FFFC is partaking in Plant Botany, specifically the development of methods and technologies to significantly enhance plant growth and purity. Under an operating agreement with Sanidor Systems to create Pure Grow Systems, LLC, FFFC acquired a 49% interest in the subsidiary, which is dedicated to the healthy production and processing of raw materials used for medicinal or other health related purposes.

The cannabis industry is a cash-only business, which leaves companies vulnerable to criminal activities. FFFC plans to address this issue and enter the Security Services and Equipment sector through the acquisition of an existing, operational security company. FFFC owns a 70% stake in Ohio-based Brawnstone Security, Inc., a diversified security, training and investigations company. FFFC's research shows that operating margins for cannabis-related security services could exceed current billing levels by at least 100%.

FFFC's Cannabis Angel, Inc. ("CA") subsidiary will evaluate and provide corporate development services and early seed financing for worthwhile development-stage cannabis ventures. To date, CA has made investments in companies involved in the distribution of cannabis-related products and development of a social media website. It is important to note that all of FFFCs activities in the cannabis industry are ancillary, or pick and shovel, and are evaluated to insure compliance with all state and federal Laws. Disclaimer

Fastfunds Financial Corp. Company Blog

Fastfunds Financial Corp. News:

Fastfunds Financial Corporation Provides Update for Subsidiary Brawnstone Security

Fastfunds Financial Corporation Announces Significant Marketing Progress for Subsidiary Pure Grow Systems One-Step Disinfectant Cleaner

Fastfunds Financial Corporation Subsidiary Pure Grow Systems, LLC to Showcase Its State of the Art Antimicrobial Sanitation System for Grow Facilities at Forthcoming Seattle Hempfest

Star Mountain Resources, Inc. (SMRS)

The QualityStocks Daily Newsletter would like to spotlight Star Mountain Resources, Inc. (SMRS). Today, Star Mountain Resources, Inc. closed trading at $1.10, up 1.85%, on 32,212 volume with 8 trades. The stock’s average daily volume over the past 60 days is 3,797, and its 52-week low/high is $0.50/$1.40.

Star Mountain Resources, Inc. (SMRS), a minerals exploration company, is focused on acquiring and consolidating mining claims, mineral leases, producing mines, and historic mines with production and future growth potential identified through exploration efforts. The company's operations are currently focused on the initiation, production and expansion of acquired mineral resources in the Star Mountain Mining District, Beaver County, Utah and turning them into producing assets.

Comprised of 2,320 acres, the company's Star Mountain/Chopar Mine project consists of 116 lode-mining claims and four metalliferous mineral lease sections located in the Star Mountain range, Star Mining District, in Beaver County, Utah, approximately five miles west of Milford, Utah. Exploration activities to date include geological analysis, and a limited reverse circulation & core drilling program.

The Star Mountain Mining District, which is dotted with historic mines dating back to the late 1800s, has a long and storied history within the mining industry. The company believes that the application of modern exploration tools will reveal additional resources that were previously unattainable. Leveraging the region's mild climate and accessibility to nearby rail lines and roads, management will look to translate this potential into sustainable returns in the years to come.

Star Mountain Resources has adopted a discovery-based business model to grow its industry presence in the future. The company plans to thoroughly explore and initially develop its leasehold before seeking senior industry partners to assist in the capital-intensive development and operation phases. Building on this strategy, Star Mountain Resources will also continue to seek quality projects that can be evaluated on their own technical and financial merit. Disclaimer

Star Mountain Resources, Inc. Company Blog

Star Mountain Resources, Inc. News:

Star Mountain Resources Inc. (SMRS) Pursues Acquisition Opportunities in North American Mining Sector

Star Mountain Resources Inc. Pursuing Acquisition of North American Base Metal Mine

StockNewsNow.com Publishes New SNN Q&A with Star Mountain Resources Inc.


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Wall Street Resources





By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251